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Abstract 
We report the first family with a dominantly inherited mutation of the nebulin gene ( NEB ). This ∼100 kb in-frame deletion encompasses 
NEB exons 14–89, causing distal nemaline/cap myopathy in a three-generation family. It is the largest deletion characterized in NEB hitherto. 
The mutated allele was shown to be expressed at the mRNA level and furthermore, for the first time, a deletion was shown to cause the 
production of a smaller mutant nebulin protein. Thus, we suggest that this novel mutant nebulin protein has a dominant-negative effect, 
explaining the first documented dominant inheritance of nebulin-caused myopathy. The index patient, a young man, was more severely 
affected than his mother and grandmother. His first symptom was foot drop at the age of three, followed by distal muscle atrophy, slight 
hypomimia, high-arched palate, and weakness of the neck and elbow flexors, hands, tibialis anterior and toe extensors. Muscle biopsies 
showed myopathic features with type 1 fibre predominance in the index patient and nemaline bodies and cap-like structures in biopsies from 
his mother and grandmother. The muscle biopsy findings constitute a further example of nemaline bodies and cap-like structures being part 
of the same spectrum of pathological changes. 
© 2019 Elsevier B.V. All rights reserved. 





















Nemaline myopathy (NM) is one of the most common
f the congenital myopathies, which include clinically,
istologically and genetically variable neuromuscular 
isorders defined on the basis of structural abnormalities in
he muscle fibres [1] . The diagnostic hallmark is nemaline
rod) bodies, stained red with the Gömöri trichrome technique
t light microscopy and appearing as dark lattice structures∗ Corresponding author. 
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960-8966/© 2019 Elsevier B.V. All rights reserved. ith electron microscopy [2,3] . In nemaline myopathy,
uscle weakness of the proximal muscles usually dominates
he clinical picture, later accompanied by a distal component,
hile severity varies from very mild to very severe. Cap
yopathy belongs to the spectrum of nemaline myopathies,
s cap-like areas are often seen together with nemaline rods
n the same patient or family. Caps are focal, peripheral areas
ith disrupted myofibrils and thickened Z lines or small
od-like structures [4,5] . Distal forms of nemaline myopathy
ave been reported in four families [6–8] . 
Mutations in eleven different genes are known to cause
emaline myopathy. Eight of these genes, alpha-tropomyosin 
 TPM3 ) (MIM: 191030) [9] , nebulin ( NEB ) (MIM: 161650)







































































































m  [10] , skeletal alpha-actin ( ACTA1 ) (MIM: 102610) [11] ,
troponin T1 ( TNNT1 ) (MIM: 191041) [12] , beta-tropomyosin
( TPM2 ) (MIM: 190990) [13] , cofilin 2 ( CFL2 ) (MIM:
601443) [14] , leiomodin-3 ( LMOD3 ) (MIM: 616112) [15] ,
and myopalladin ( MYPN ) (MIM: 608517) [16] genes
encode structural components of the muscle sarcomere thin
filament. The other three genes, Kelch repeat- and btb/poz
domain-containing protein 13 ( KBTBD13 ) (MIM: 613727)
[17] , Kelch-like gene family member 40 ( KLHL40 ) (MIM:
615340) [18] , Kelch-like gene family member 41 ( KLHL41 )
(MIM: 607701) [19] genes encode proteins involved in the
stability or turnover of the thin filament. Mutations in TPM2 ,
TPM3 , ACTA1 and MYPN have been reported to cause
cap myopathy or cap-like structures in addition to nemaline
rods [5,20–24] . The mode of inheritance of the nemaline
myopathies may be dominant or recessive, or the disorder
may be caused by a de novo dominant mutation. 
The vast majority of patients with NEB mutations
have been diagnosed with nemaline myopathy. However,
NEB mutations have also been identified in patients
with distal nebulin myopathy (four families) [25] , distal
nemaline myopathy (three families) [6] , core-rod myopathy
(one family) [26] , distal core-rod myopathy (one family)
[27] and fetal akinesia/lethal multiple pterygium syndrome
(four families) [7,28] . Thus, the NEB -caused myopathies
characterized to date constitute a clinically, histologically and
genetically heterogeneous group of muscle disorders. 
Distal myopathies, likewise showing a spectrum of
histopathological findings and clinical phenotypes, have
varying ages of onset of symptoms from early childhood to
late adulthood, and varying patterns of muscle involvement
[29,30] . Several genes have been identified as causative of
distal myopathies, some of which cause other myopathy
phenotypes also, and the mode of inheritance is either
autosomal recessive or dominant depending on the causative
gene [29,30] . 
Nebulin is one of the largest proteins in vertebrates
(600–900 kDa), encoded by the 249 kb NEB gene including
183 exons with a theoretical full-length cDNA sequence
of 2.6 kb (Ref.Seq. NM_001271208). Nebulin is expressed
mainly in striated muscle, where it is essential for stabilising
the thin (actin) filament of the muscle sarcomere as well as
for the proper functioning of muscle contraction [31,32] . The
extensive alternative splicing of NEB creates a high number of
different nebulin isoforms [33] . Nebulin is a highly conserved
protein consisting of simple and super repeats. The middle
part of nebulin contains a triplicate region in which eight
exons are repeated three times almost identically [31–33] . 
To date, we have identified more than 240 different
disease-causing variants in NEB in more than 210 families
[7,34,35] . The majority are unique, or present in only a
few families. Of the affected families, 80% carry compound
heterozygous and 20% homozygous NEB mutations [7,34,35] .
Of all the different NEB mutations, 95% consist of point
mutations and small indels, whereas different large copy
number variations (CNV) are rare, accounting for only 5%
of the mutations [7,35] . However, copy number variationf the NEB triplicate region was shown to be recurrent and
resent in 14% in a cohort of 270 families studied using
he nemaline myopathy-comparative genomic hybridisation
rray (NM-CGH Array). NEB triplicate region CNV was
nterpreted to be disease-causing in 4% of the families [35] .
n addition to the well-described NEB exon 55 deletion and
he recurrent NEB triplicate region CNV, we have identified
1 different pathogenic large duplications and deletions in
EB . Of the 210 families with one or both pathogenic NEB
ariations identified, 17% carry a large pathogenic CNV
unpublished data). All mutations characterized in NEB
hus far have shown recessive inheritance [7,35] . Of the
40 different NEB mutations, 90% have been identified as
ompound heterozygous and 7% both as homozygous and
ompound heterozygous, while 3% of the mutations were
dentified as homozygous only. 
Most of the NEB mutations identified in the ten published
amilies with distal nebulin or distal nemaline myopathy have
lso been identified in nemaline myopathy and/or core-rod
yopathy patients [6,7,25,27] . Hitherto, large CNVs in NEB
ave been identified only in patients with recessive nemaline
yopathy. 
Here, we present the first description of a dominantly
nherited NEB mutation. This novel ∼100 kb in-frame deletion
as found to cause a distal form of nemaline/cap myopathy
n a three-generation Finnish family. 
. Materials and methods 
.1. Patients 
The patients enrolled in the study were the index patient
III-1), his mother (II-2) and maternal grandmother (I-3)
 Fig. 1 ). The index patient ( Fig. 2 A–D) presented with muscle
eakness at the age of 3 years, and subsequently his mother
 Fig. 2 E–F) and maternal grandmother were also found to be
ffected. Moreover, the healthy siblings of the mother and
randmother were clinically examined, with normal results,
nd the maternal uncle underwent muscle CT, with a normal
esult. 
.2. Samples 
We received genomic DNA samples and muscle biopsies
rom the three patients (I-3, II-2 and III-1), and DNA
amples of ten healthy first-degree relatives for segregation
tudies ( Fig. 1 ). The study has been approved by the Ethics
ommittee of the Children’s Hospital, and the Helsinki
niversity Hospital, University of Helsinki, Helsinki, Finland.
.3. Molecular genetic studies 
In order to identify the causative mutation(s) in this
amily, mutations known to cause distal myopathies were
creened in the patients (I-3, II-2, III-1), including known
utations in titin ( TTN ), myosin heavy chain 2 ( MYH2 ),
yosin heavy chain 7 ( MYH7 ), myotilin ( MYOT ) and Z-disc
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Fig 1. Family tree and the haplotypes. The family tree and the haplotypes of each individual genotyped in the NEB region in chromosome 2. The microsatellite 
markers locate around NEB and SNPs are within the gene region. The colours of the haplotypes visualize the inheritance patterns of the alleles. The deleted 
allele is presented in yellow font (I-3, II-2 and III-1). Asterisks indicate the SNPs analysed in the cDNA. The heterozygosity of the SNPs show that both ends 










































u  ssociated alternatively spliced gene encoding a PDZ-LIM
omain-binding 3 protein ( ZASP ) genes. The DNA sample of
he index patient (III-1) was checked by Sanger sequencing
or the pathogenic NEB variants hitherto identified in the
innish population ( NEB exons 8, 32, 50, 54, 61, 65, 68,
5, 117, 122, 134, 136, 142, 151, 163, 173 and 182). These
innish NEB variants are listed in the LOVD database and in
ur previous publications [7,10,35,36] . 
Whole-genome linkage analyses were performed at
eCode (Iceland). The NEB haplotypes for the family were
onstructed using single nucleotide polymorphisms (SNPs) in
he exons 4, 10, 31, 65, 122, 151, 173 and 181 for all the
3 family members from whom DNA samples were available
three affected and 10 unaffected family members) ( Fig. 1 ). 
The Array Comparative Genomic Hybridization Method 
Oxford Gene Technology IP Limited, Oxford, UK) was used
or targeting the known nemaline myopathy genes with a
igh-density tiling approach in our custom NM-CGH 8 ×60 k
icroarray. In addition, the CytoSure ISCA + SNP 4 ×180 k
rray was used to analyse copy number variations of the
hole-genome. The labelling, hybridisation and scanning 
as done according to the manufacturer’s protocol andata analysis and interpretation was done using CytoSure
nterpret Software v.4.9. (GRCh37) as previously described
37] . The CBS algorithm was used with segmentation-based
ormalisation and specific settings created for the GC-rich
robes for the NM-CGH Array analysis. All 13 family
embers were analysed using the NM-CGH Array. 
Multiplex ligation-dependent probe amplification (MLPA) 
as performed using the MLPA SALSA kit according to
he manufacturer’s protocol (MRC-Holland, Amsterdam, The 
etherlands), using self-designed oligonucleotide probes to 
arget the following regions of NEB : the promoter region
nd exons 14, 24, 52, 55, 86, 87, 89, 106, 171, 180, 183
detailed probe information available on request). MLPA was
erformed and analysed as previously described [37] . All
hree affected family members and seven unaffected family
embers were analysed using MLPA. 
Whole-exome sequencing (WES) was performed with two
ifferent approaches. The first WES was done using Axeq
orea/USA (Illumina TruSeq) of one affected (II-2) and
ne unaffected family member, a maternal uncle (II-1). The
econd WES method was done on the index patient (III-1)
sing Agilent SureSelectXT All Exon 50Mb target enrichment
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Fig. 2. The index patient and his mother. (A–C) The index case (III-1) with mainly distal muscle atrophy and weakness of the wrist and finger extensors as 

































































n  kit (protocol v1.2; Agilent Technologies, Santa Clara, CA,
USA) on an Illumina HiSeq2000 platform using TruSeq v3
chemistry (Illumina Inc, San Diego, CA, USA) and analysis
was completed using the Oxford Gene Technology exome
sequencing pipeline. 
Conventional karyotyping of the mother (II-2) was
performed in blood lymphocytes using G-banding. All
183 NEB exons and exon-intron boundaries were Sanger
sequenced and RT-PCR of NEB was performed using mRNA
from the muscle biopsy samples of the index patient (III-1)
and his mother. Moreover, the variants identified in MYH2 ,
MYBPC1 and DYS were sought for by sequencing in all 13
family members. 
All primer sequences and PCR details are available from
the corresponding author. 
2.4. Western blot analysis 
Frozen muscle sections (20 sections, thickness 12 μm)
were prepared in pre-chilled Eppendorf tubes. To prepare
crude myofibrillar fractions, ice-cold TE-sucrose (Tris-EDTA,
pH 7.4, with 0.25 M sucrose and Halt Protease Inhibitor Mix,
(Thermo Scientific) was added, following by vortexing full
speed for 60 s. The mixture was centrifuged 1,000 × g
for 15 min. The pellet was washed with TE-buffer and
dissolved in WB sample buffer (Laemmli buffer with 20 mM
EDTA and 4 M urea), mixed by vortexing and incubated
at room temperature for 15 min. Insoluble material was
discarded after centrifugation, and the supernatant was used
for SDS-PAGE. Equal amounts of the samples were run on
standard 12% SDS-PAGE gels and stained with Coomassie
blue to assess the total protein content in each sample.
Volumes were then adjusted to obtain equal protein loading.
Ready-cast 7.5% TGX gels (Bio-Rad Laboratories, CA, USA)
were used to separate the nebulin protein by running 18 h at
50 V. The proteins were transferred onto PVDF membranes
using Bio-Rad TransBlot Turbo blotting device, Standard
SD program (25 V), 40 min. The filters were incubated withrimary antibody, clone NEB 9C4 B5E5 (provided by Glenn
orris, Oswestry), at 1:300 dilution at + 8 °C for 18 h, with
entle agitation, and detected using ECL. ChemiDoc reader
nd ImageLab software (Bio-Rad Laboratories) were used to
btain images and for calculating the molecular weights of
he bands of unknown size. 
.5. Immunolabelling of muscle sections 
Immunolabelling was performed on 10 μm sections of
uscle frozen in isopentane cooled in liquid nitrogen.
ections were immunolabelled with primary antibodies
gainst N-terminal nebulin (rabbit polyclonal H-300, diluted
:10 in 1% bovine serum albumin, BSA; SC28286, Santa
ruz, Dallas, TX, USA), and nebulin super repeat S21 (mouse
onoclonal 9C4 B5E5, diluted 1:100; provided by Glenn
orris, Oswestry). 
Alexa Fluor Donkey anti-Rabbit 488 (1:500 in 1% BSA;
21206, Thermo Fisher Scientific Waltham, MA, USA) was
sed as the secondary antibody for the N-terminal nebulin
-300-ab, and Alexa Fluor Goat anti-Mouse 546 (1:500 in 1%
SA; A11003, Thermo Fisher Scientific) for the S21-mAb. 
The sections were fixed in 4% PFA (paraformaldehyde)
or 10 minutes, permeabilised in 0.2% Triton X-100 for 10
inutes and blocked in 5% BSA for 30 minutes before adding
he primary antibody (at + 4 °C o/n). The secondary antibody
as allowed to bind for 1 h at RT. Hoechst (1:5000 in PBS,
hermo Fisher Scientific) was added to counterstain nuclei
efore mounting in Fluoromount (Sigma-Aldrich, St. Louis,
O, USA). Optical sections of 0.9 μm were imaged using a
EISS LSM 880 confocal microscope. 
. Results 
.1. Clinical findings 
The index patient (III-1) was the first child of
on-consanguineous Finnish parents. His neonatal period and
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Fig. 3. CT scans of lower leg muscles. (A) The index case (III-1) at the age of 12 years shows complete fatty degeneration of all anterior compartment 
muscles and minor diffuse degenerative change in posterior calf muscles. (B) The mother (II-2) at the age of 45 years shows complete fatty degeneration 
of all anterior compartment muscles and minor diffuse degenerative change in the soleus muscles. (C) The grandmother (I-3) at the age of 64 years shows 


























i  nfancy were medically unremarkable. At the age of three,
e was noted to have foot drop, which led to investigations
t the Children’s Hospital, University of Helsinki at the age
f 4.5 years. On examination, he was found to have an
longated face. He was unable to walk on his heels, hopping
n one leg was difficult and the extensors of the big toes
ere weak. The strength in other muscle groups was normal.
lectromyography showed small motor unit potentials and
eurography showed normal conduction velocities. Serum 
oncentrations of creatine kinase were normal (116 IU/l,
ormal range 20–220 IU/l). A tentative diagnosis of tibial
uscular dystrophy (TMD) was made, the early age of
nset and the facial weakness however making this diagnosisnlikely. CT scans of the lower leg muscles at the age of 10
ears showed extensive atrophy and fatty degeneration of all
nterior compartment muscles ( Fig. 3 A). 
Since then, the course of the disease has been slowly
rogressive. The young man, now aged 30 years, reported
light difficulties doing push-ups and rising from the squatting
osition, grip strength having become weaker, and carrying
eavy loads more difficult. He was able to climb stairs, albeit
 bit slowly. 
On examination at the age of 30 years, he was a tall,
lender man with moderate atrophy of the distal muscles of
he upper and lower limbs. Atrophy was especially evident
n the anterior lower legs, thenar, hypothenar and EDB












































































































A  muscles, with asymmetry of the calf muscles, the right being
thinner ( Fig. 2 A–B). He had a slight hypomimia and clearly
high-arched palate. Both ankles had 90 ° contractures and the
feet were high-arched ( Fig. 2 C). On muscle testing, the neck
flexors and the finger extensors ( Fig. 2 D) were especially
weak, 2/5 on the MRC scale, while toe and finger flexors had
a strength of 4. He was unable to walk on his heels, hopping
on one leg was more difficult on the right, and the ankle
dorsiflexors as well as the toe extensors showed a weakness
of 0. The shoulder girdle muscles and elbow flexors had a
power of 4, while all other muscles showed normal strength.
The mother (II-2) of the index patient was doing well
in terms of her muscle strength and had not sought
medical attention because of any weakness noted. She had,
however, undergone surgery for a benign brain tumour, the
operation and the post operative immobility leaving her with
asymmetric muscle weakness and slight difficulties keeping
her balance. Subsequently, she had not noted any additional,
clear deterioration in muscle strength. 
As a child, by history, she had good physical endurance,
although not as good as the best of her peers, and
she participated in long-distance cross-country skiing
competitions. She reported always having had a slight
clumsiness. Examinations initiated at the age of 35 years
because of the tentative diagnosis of TMD in her son showed
marked weakness of ankle dorsiflexion, and on muscle CT
scans, fatty degeneration of the anterior compartment muscles
of the lower legs ( Fig. 3 B). 
On examination at the age of 57 years, she had a normal
build, with slight atrophy of the distal muscles of the upper
and lower limbs, including the wrist flexors and extensors,
all hand muscles, especially the thenar muscles and the
interossei, and the anterior compartment of the lower legs
( Fig. 2 E). She had a mild scoliosis and low arches of the
feet. She had slight hypomimia ( Fig. 2 F) and somewhat
high-arched palate. She was unable to walk on her heels and
had difficulty getting up from the squatting position. Muscle
testing revealed a weakness of 0/5 in the ankle dorsiflexors
and the toe extensors, of 4 or 4 + in the neck flexors, the
shoulder girdle, the extensors and flexors of the wrists and
the flexors of the fingers, while the finger extensors were
clearly weaker (4-). The axial muscles showed only very
slight weakness (5-), while the strength of the knee flexors
and extensors, the ankle and the toe plantar flexors was
normal. Serum concentrations of creatine kinase were normal.
The maternal grandmother (I-3) of the index patient was
first examined at the age of 60 years as part of the family
study. She had not previously sought medical attention for
any muscle weakness. She had, however, had foot drop as
long as she could remember, and had been unable to stand
on her heels since the age of 10 years. CT scans of the
lower leg muscles showed extensive fatty degeneration in all
anterior compartment muscles of the lower legs ( Fig. 3 C).
When examined at the age of 73 years, she had weakness of
2/5 in the ankle dorsiflexors, 4 in the neck flexors and 5- in
the proximal parts of the lower limbs. Serum concentrations
of creatine kinase were normal. .2. Muscle histopathology 
A muscle biopsy from the quadriceps femoris muscle of
he index patient (III-1) at the age of 4 years showed
arked fibre type 1 predominance. No specific structural
bnormalities were identified in the muscle fibres, and G ӧm ӧri
richrome staining as well as toluidine blue-stained semithin
ections failed to reveal any nemaline rods. The second biopsy
rom lower leg muscles taken in the context of surgery at the
ge of 12 years showed type 1 predominance and a biphasic
istribution of type 1 fibre size, with fibre sizes ranging
rom 10 to 90 μm in diameter ( Fig. 4 A). The third biopsy
btained from the gastrocnemius medialis muscle of III-1
t the age of 28 years showed end-stage fibrotic pathology
nd severe atrophy involving both fibre types. Occasional
ytoplasmic bodies and thickened Z discs were observed on
 ӧm ӧri trichrome staining. Typical nemaline rods were not
bserved in any of the biopsies. 
Gastrocnemius medialis biopsies were obtained from the
randmother (I-3) at the age of 73 years and from the
other (II-2) at the ages of 45 and 55 years. Those from
he mother revealed type 1 fibre predominance of more than
0%. There was an excess of fibrous and fatty tissue, as well
s atrophy involving both type 1 and 2 fibres. Fibres of both
ypes showed numerous randomly distributed sarcoplasmic
emaline bodies and clusters of nemaline bodies also in
eripheral cap-like areas ( Fig. 4 B–D). Subsarcolemmal
ale-staining cap structures were also identified. In
ddition, some peripheral areas contained bright-red
tructures corresponding to clusters of nemaline rods. The
istopathological findings in the biopsy of the grandmother
I-3) were similar, except that type 1 fibre predominance was
ot observed. On electron microscopy nemaline bodies and
ap-like structures were identified in both patients’ (I-3 and
I-2) biopsies ( Fig. 4 E–F). 
The confocal microscopy confirmed the presence of both
nds of nebulin in muscle tissue of the index patient
 Fig. 4 G–I). No structural abnormalities or protein aggregates
ere detected with either of the nebulin antibodies. 
.3. Genetic findings 
Using the NM-CGH Array a massive deletion removing
he exons 14–89 of NEB was detected ( Fig. 5 A). This deletes
99–106 kb of genomic DNA. The deletion covers exons
4–81 ∼89–96 kb, and one copy of the NEB triplicate region
exons 82–89) ∼10 kb in size. 
The molecular karyotype of the three affected family
embers according to the HGVS nomenclature is;
hr2:g.(152454645_152456955)_(152554712_152561404)del 
GRCh37) relating to c.(1257 + 1_1258–1)_(13,788 +
_13,789–1)del. 
The NM-CGH Array did not reveal the exact breakpoint
esiding in intron 13 because of a 6.7 kb gap between
robes. The reason for the design not including probes in
his particular region is that the sequence contains various
lu and LINE1 sequence repeats, hindering the designing of
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Fig. 4. Biopsy findings of the index patient (III-1). (A) Lower leg muscle biopsy of the index patient (III-1) at the age of 12 years double-stained with MyHC 
slow (brown) and MyHC fast (2A fibres red) demonstrates variation of fibre size and type 1 fibre predominance. (B-D) All type 2A fibres are very small 
(arrow). Gömöri trichrome stains of GM muscles of the grandmother (I-3) at the age of 73 years (B) and of the mother (II-2) at the age of 45 years (C, 
D) show red-staining nemaline rods in the intermyofbrillar spaces and clusters of nemaline rods in peripherally located cap-like structures. (D) Pale green or 
grey subsarcolemmal cap-like structures with disorganized myofibrillar structure are also present (arrow). (E) Electron microscopy of the GM muscle biopsy 
of II-2 shows a cluster of longitudinally and transversely oriented electron-dense nemaline rods located at the periphery of the fibre. (F) On the right side of 
the micrograph a subsarcolemmal cap structure with disorganized thin filaments and thickened Z discs is shown. Scale bar = 100 μm (A–D), scale bar = 1 μm 
(E–F). (G-I) Immunofluorescence staining of muscle sections: Confocal microscopy of the nebulin N-terminus at the thin filament pointed end (G) and super 
repeat 21 (S21) (H), flanking the Z disc, in the index patient (III-1). Staining confirmed the expression of both ends of nebulin in correctly assembled 
sarcomeres (I). No protein aggregates were observed. The images show a single optical section of 0.9 μm. Scale bar = 5 μm. 
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Fig. 5. (A) NM-CGH array and the Western blot profiles of the three affected 
family members. The array profiles of the index patient (III-1), the mother 
(II-2) and the grandmother (I-3) all show the same deletion of NEB exons 
14–81 as well as a one-copy loss of the NEB triplicate region (exons 
82–89). (B) Nebulin Western blot analysis shows the corresponding short 
nebulin isoforms present in the affected family members. The full-size 
nebulin bands were designated as 986 and 773 kDa (Uniprot P20929), and 































































m  unique probes. The other breakpoint is interpreted to reside
in intron 89, leading to loss of one copy of the NEB triplicate
region. Thus, two copies of the triplicated region remain in
the mutated allele, and the patients each have a total of 5/6
copies. The same deletion pattern was found to be present inll three affected family members, indicating that the mutation
onstitutes one single deletion affecting one allele. 
We analysed the DNA samples also from ten unaffected
amily members and they showed normal array profiles of
EB . 
The deletion was verified using MLPA in all three affected
amily members. In addition, samples from seven unaffected
elatives were studied, yielding normal results. We tried to
eveal the exact breakpoints by sequencing the genomic
NA of the index patient (III-1). Despite several sequencing
ttempts, this could not be achieved. Based on our previous
tudies, we know that the repetitive triplicate region may
ause major difficulty in Sanger sequencing. 
Prior to doing the NM-CGH Array analysis, we excluded
ll known Finnish distal myopathy mutations and NEB
utations in the index patient using Sanger sequencing
III-1). To locate the causative gene for this family,
hole-genome linkage analysis was performed. The affected
amily members shared one haplotype spanning both NEB
nd TTN on chromosome 2, which was compatible with
inkage to a possible dominantly inherited disease. The
rst exome sequencing was performed on samples from
he mother of the index patient (II-2), and one unaffected
amily member, a maternal uncle, II-1 ( Fig. 1 ) (Illumina
ruSeq). The most promising rare variants were analysed by
anger sequencing in all affected family members. However,
his did not reveal the causative gene. After that, the
M-CGH Array was performed, revealing the large deletion
n NEB . 
As only recessive mutations have been characterized in
EB previously, we sequenced all 183 nebulin exons of the
ndex patient (III-1) and his mother (II-2). We failed to find
 second pathogenic variant in NEB . Subsequently, the entire
EB cDNA of the mother was sequenced, excluding deep
ntronic mutations possibly disrupting the correct splicing of
EB . No additional mutations were detected. Studying muscle
DNA from the index patient and his mother, we found that
eterozygous SNPs were present at the 5 ′ and 3 ′ ends of
EB , verifying the expression of both NEB alleles ( Fig 1 ).
his gave further support to the hypothesis of dominant
nheritance. 
Haplotyping in all the 13 family members using genomic
NA showed homozygosity for the middle part of NEB in
he affected family members only. Furthermore, haplotypes
f the grandmother (1–3) and her siblings revealed that the
randmother’s myopathy was due to a de novo mutation. 
We also did a second WES study of a DNA sample of
he index patient (III-1), using the Agilent SureSelectXT All
xon 50Mb target enrichment kit, to see if any pathogenic
ariants in other genes could have been missed. We identified
eterozygous missense variants in MYH2 (p.Ile1515Thr) and
n MYBPC1 (p.Val337Ile) in the index patient, as well
s in the healthy father (II-3), but neither of them in
he affected mother (II-2). Moreover, a variant, c.957G > T:
.Trp319Cys, was identified in heterozygous form in the
-chromosomal dystrophin gene in the index patient, the
other, the grandmother (I-3) and also in the unaffected














































































































J  aternal uncle (II-1). As this variant was identified in the
naffected uncle, we considered it to be non-pathogenic. 
We studied the DNA sample of the index patient (III-1)
lso using a whole-genome 4 ×180k ISCA + SNP array. This
id not reveal any other CNVs. 
Furthermore, we analysed the karyotype of the mother
II-2) in blood lymphocytes to exclude any chromosomal
earrangements, such as balanced translocations. Her
aryotype was normal. 
To assess the expression of the mutant allele at the
rotein level, a Western blot analysis was performed of
yofibrillar protein lysates extracted from the muscles of all
hree affected family members, and from healthy controls.
his analysis showed that in addition to the normal-sized
approximately 800 kDa) nebulin protein, there were two
maller mutant proteins present in the samples from the
ffected family members that were not present in the
ontrol samples ( Fig. 5 B). The calculated size of the mutant
ebulin is 470 kDa. This provides evidence that the mutant
llele produces smaller-sized nebulin proteins, which are not
egraded and show stable expression levels. 
. Discussion 
We present here the first dominantly inherited NEB
utation as the cause of a mild distal myopathy presenting in
hildhood with foot drop. Because of their mild symptoms,
he mother (II-2) and grandmother (I-3) in the family were
nly examined after the clinical diagnosis in the index patient
III-1) had been made. There was mild facial involvement
nd weakness of the neck flexors, wrist extensors, all hand
uscles, especially the finger extensors, tibialis anterior, long
oe extensors and EDB, with a later proximal involvement
ncluding the shoulder girdle and elbow flexors. 
This distribution of muscle weakness is similar to that seen
n Laing distal myopathy caused by dominant mutations in the
yosin heavy chain gene MYH7 [38,39] , and to that seen in
ecessively inherited distal nebulin myopathy [25] , with finger
xtensors being weaker than the flexors. Better preservation
f index finger extension compared with the other fingers, as
ay be present in recessive distal nebulin myopathy and in
aing distal myopathy, was not observed. These two disorders
re the closest differential diagnoses to keep in mind. 
Other distal myopathies with foot drop as the presenting
eature need to be considered in the differential diagnostic
ork-up [30] . 
We describe a novel large pathogenic deletion in NEB
n a family with three affected nemaline/cap myopathy
atients in three generations. This ∼99–106 kb deletion in
EB covers exons 14–81 as well as one copy of the NEB
riplicate region (exons 82–89). Despite extensive genetic
tudies using a number of different approaches, no other
athogenic mutations were identified in the known nemaline
yopathy-causing genes or in any other plausible candidate
enes. 
Analysing mRNA from the muscle biopsies of the patients,
e were able to demonstrate the presence of both allelesf muscle NEB cDNA. Thus, the mutant allele is being
xpressed. Importantly, Western blot analysis verified that
he mutant protein is being produced, showing two smaller
ebulin proteins present in the muscle biopsies of the affected
amily members. 
Based on the evidence above, we conclude that a
ominant-negative effect of the smaller-than-normal nebulin 
rotein is the likely cause of the nemaline myopathy in these
atients. 
In addition to the large deletion in NEB , we identified
 missense mutation in MYH2 (p.Ile1515Thr) in the index
atient (III-1) and the father (II-3), but not in the mother
II-2). The question was considered whether this alteration
ight have a modifying effect, perhaps explaining the more
evere clinical picture of the index patient compared with
he mildly affected mother and grandmother (I-3). However,
YH2 is expressed in fast 2A fibres, while the biopsies
f the index patient showed mainly type 1 fibres. Since
he mother, not carrying the MYH2 variant, had a similar
bre type distribution and the target muscle tibialis anterior
s a muscle with type 1 predominance, an effect of the
YH2 variant appears unlikely as the explanation. According
o the ExAC browser ( http:// exac.broadinstitute.org/ variant/ 
2- 102040659- G- A), the missense variant p.Val337Ile in
YBPC1 , identified in the index patient and his father, has an
llele frequency of 0.005 in the Finnish population. MYBPC1
s predominantly expressed in slow muscle fibres, and a
odifying effect of this variant cannot be excluded. 
Although the index patient (III-1) underwent two muscle
iopsies, typical nemaline bodies were not observed. This
ight be due to sampling error or it might be age-related,
s a number of patients with nemaline myopathy have been
escribed to show no nemaline bodies in their first biopsy or
nly show them in the electron microscopy sample [40–44] .
here are many previous reports of families with congenital
yopathy where the histological pictures vary between family
embers, despite their sharing the same mutation [45,46] .
oreover, it is known that cap formation and quantities of
emaline bodies may vary between family members [5,21] .
emaline rods can be present in focal peripheral zones;
imilarly cap-like areas can be focal and contain thickened
-disc material. Rods and cap-like areas may thus be parts of
 pathological spectrum [5,21] . 
To date, we have screened 270 families with nemaline
yopathy or related myopathies using the NM-CGH Array,
nd identified 15 different disease-causing copy number
ariations in NEB in 31 families. There are still more than 60
amilies in which we have only identified one NEB mutation,
hile the second one remains unknown. The present study
ndicates that in some rare cases a large aberration in NEB
an be dominant, while point mutations and small insertions
nd deletions should still be considered recessive. 
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